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Fe/S clusterRNA molecules are decorated with various chemical modiﬁcations, which are introduced post-transcriptionally
by RNA-modifying enzymes. These modiﬁcations are required for proper RNA function. Among more than 100
known species of RNA modiﬁcations, several modiﬁed bases in tRNAs and rRNAs are introduced by RNA-
modifying enzymes containing iron–sulfur (Fe/S) clusters. Most Fe/S-containing RNA-modifying enzymes con-
tain radical SAM domains that catalyze a variety of chemical reactions, including methylation, methylthiolation,
carboxymethylation, tricyclic purine formation, and deazaguanine formation. Lack of these modiﬁcations can
cause pathological consequences. Here, we review recent studies on the biogenesis and function of RNA modiﬁ-
cations mediated by Fe/S proteins. This article is part of a Special Issue entitled: Fe/S proteins: Analysis, structure,
function, biogenesis and diseases.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
RNA molecules contain various types of qualitative information
that cannot be deduced from the genome sequence, including post-
transcriptional modiﬁcations and editing, as well as terminal chem-
ical structures that are required for proper RNA function. Over 100
different modiﬁcations have been identiﬁed in RNAmolecules across
all domains of life [1]. These modiﬁcations are chemically diverse, and
include methylation, hydroxylation, acetylation, deamination, isom-
erization, selenylation, reduction, cyclization, and conjugation with
amino acids and sugars. Several novel RNA modiﬁcations have been
reported over the past few years, and as analytical technologies have
developed, the chemical space of RNA modiﬁcation is expanding. In
contrast to the limited range of DNA modiﬁcations, the wide variety of
RNA modiﬁcations appears to be a strategy by which RNA molecules
acquire a greater variety of cellular functions.
Modiﬁcations of RNA molecules stabilize tertiary structures, modu-
late afﬁnity for RNA-binding proteins, regulate decoding of genetic
information, and determine the subcellular localization and lifetime of
RNAs. However, the exact function and biogenesis of many of these
modiﬁcations remain to be determined. RNA modiﬁcations are intro-
duced by members of various families of RNA-modifying enzymes,
including Fe/S proteins (Fig. 1). Most Fe/S proteins involved in RNA
modiﬁcations (Table 1) have radical S-adenosylmethionine (SAM)
domains that produce 5′-deoxyadenosyl (5′dAdo) radicals, and thereteins: Analysis, structure, func-
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.enzymes catalyze diverse chemical reactions, including C\C or C\S
bond formation [2,3]. Here, we review recent studies on the biogenesis
and function of RNA modiﬁcations mediated by Fe/S enzymes.
2. Methylation via radical SAMmotif
In Escherichia coli, 2-methyladenosine (m2A) is present at position
2503 in 23S rRNA (Fig. 2A) [4], as well as at position 37 of a subset of
tRNAs (Fig. 2B) [5]. RlmN is a radical SAM-dependentmethyltransferase
responsible form2A2503 formation in 23S rRNA [6,7]. Themodiﬁed res-
idue m2A2503 is located at the entrance of the ribosome exit tunnel,
where it regulates translation elongation by interacting with nascent
peptides. This modiﬁcation is involved in resistance to several antibi-
otics that target the large ribosomal subunit [6], as well as in pro-
grammed ribosome stalling for regulated expression of some inducible
antibiotic-resistance genes [8]. m2A2503 formation by recombinant
RlmN in the presence of SAM has been successfully reconstituted
in vitro (Fig. 2C) [7]. As its substrate, RlmN employs naked 23S rRNA,
but not the fully assembled large ribosomal subunit, suggesting that
m2A2503 formation takes place during ribosome assembly. To intro-
ducem2A2503, RlmNprimarily recognizes Helices 90–92with the adja-
cent single-stranded RNA. In addition, RlmN is responsible for the
synthesis of m2A at position 37 of some tRNAs [9]. RlmN introduces
m2A37 on tRNA in vitro in the presence of SAM. Deletion of rlmN results
in elevated misreading [9], suggesting that m2A37 plays a role in main-
taining translational ﬁdelity.
The cfr gene, isolated in Staphylococcus sciuri, confers resistance to
several antibiotics, including chloramphenicol, in Staphylococcus spp.
and E. coli [10,11]. Like RlmN, Cfr is a radical SAM-dependent methyl-
transferase that targets A2503 in 23S rRNA, but Cfr catalyzes formation
of 8-methyladenosine (m8A) (Fig. 2C) [12]. Although both RlmN and
Fig. 1. Pathways of RNA modiﬁcations mediated by Fe/S proteins in eukaryotic cells.
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dependently. Thus, 2-, 8-dimethyladenosine can be produced at posi-
tion 2503 by the serial action of the two enzymes.
In contrast to general SAM methyltransferases, RlmN and Cfr both
possess a radical SAM motif, and radical formation is required for their
methylation reactions [7]. SAM is widely used as the methyl group
donor for methylation of a substrate via the SN2 displacement reaction
catalyzed by a SAM-dependent methyltransferase. In the case of RlmN
and Cfr, however, only two of three hydrogens of the methyl group in
SAM are transferred to the RNA substrate [13]. The remaining hydrogen
of the methyl group is derived from the hydrogen originally bound to
the C2 position of the adenine base of the substrate RNA [13]. In other
words, RlmN and Cfr employ a unique catalytic mechanism in which
the methyl group is generated on the substrate RNA. Several lines of
evidence [14–18] suggest a plausible catalyticmechanism for the radical
SAM-dependent methyltransfer reaction utilizing two SAM molecules
(Fig. 2D). In this model, the conserved Cys residue (Cys355 in E. coli)
on RlmN is methylated by SAM via a canonical SN2 displacement reac-
tion. Consistent with this, methylated Cys355 was clearly visible in the
crystal structure of apo form of RlmN with SAM [14]. In parallel, the
Fe/S cluster on the radical SAM domain catalyzes a reductive cleavage
of another SAM molecule to produce a 5′dAdo radical, releasing Met
as a by-product. Next, the 5′dAdo radical abstracts the H-atom of the
methylated Cys residue, generating amethylene radical. Themethylene
radical of RlmN adds to the C2 position of the adenine base, forming a
covalent RlmN–RNA conjugate. After releasing an electron, deproton-
ation at the C2 position takes place. The other conserved Cys residue
(Cys118 in E. coli) then forms a disulﬁde bond with Cys355 to release
RlmN from the substrate RNA. When Cys118 is substituted with
Ala, the RlmN–RNA conjugate can be detected [15,16]. Finally, the
deprotonated H-atom is added to the ethylene group to complete the
reaction.3. Methylthiotransferases responsible for the tRNA modiﬁcation
Sulfur atoms are often incorporated in tRNAs as post-tran-
scriptional modiﬁcations [19]. A subset of tRNAs that decode U-
starting codons (UNN) and A-starting (ANN) codons harbor 2-
methylthio-N6-isopentenyladenosine (ms2i6A) and 2-methylthio-
N6-threonylcarbamoyladenosine (ms2t6A), respectively, at position
37 (Fig. 3A). Because this position is 3′ adjacent to the anticodon,
the methylthio group of ms2i6A37 stacks on the codon–anticodon
helix in the decoding center of ribosome [20], facilitating accurate
decoding of tRNA. In addition, methylthio modiﬁcation of ms2i6A37
is engaged in reading-frame maintenance [21] and is required for
the attenuation activity of some operons involved in aminoacid
biosynthesis [22].
Members of themethylthiotransferases (MTTase) protein family are
involved inmethylthiolation of RNAs and proteins. MTTases belong to a
subset of radical SAM enzymes that contain two [4Fe-4S] clusters [3,23].
RNA MTTases are classiﬁed into two types, MiaB and MtaB, which are
responsible for ms2i6A and ms2t6A formation, respectively (Fig. 3B)
[24–27]. RimO is another MTTase that catalyzes methylthiolation of an
Asp residue in ribosome protein S12 [28–30].
Thebiogenesis ofms2i6A beginswith isopentenylmodiﬁcation of the
N6 amino group of A37, catalyzed by MiaA, to form i6A [31]. Thereafter,
a methylthio group is transferred to C2 position of i6A37 by MiaB
(Fig. 3B)[24,25]. MiaB then recognizes the N6-isopentenyl group of i6A
to introduce the 2-methylthio modiﬁcation [32]. In the case of ms2t6A
formation, t6A is ﬁrst synthesized by four enzymes (TsaB, TsaC, TsaD,
and TsaE) [33], and then methylthiolation of t6A is catalyzed by MtaB
(Fig. 3B) [26]. As t6A is further modiﬁed to cyclic t6A (ct6A) catalyzed
by TcdA in bacteria, fungi, plant and some protists [34], MtaB might be
responsible for formation of 2-methylthio-cyclic t6A (ms2ct6A) in
organisms in which both TcdA and MtaB are present.
Table 1
RNA modiﬁcations mediated by Fe/S enzymes.
Enzyme Modiﬁcation Substrate Product Reaction RNA
substrate
Position Other substrates Radical
SAM
Number of FeS
clusters
Human
homolog
MiaB ms2i6A i6A ms2i6A Methylthiolation tRNA 37 Sulfur, SAM Yes 2 CDK5RAP1
MtaB ms2t6A t6A ms2t6A Methylthiolation tRNA 37 Sulfur, SAMa Yes 2 CDKAL1
QueE Q CPH4 CDG Ring contraction tRNA 34 SAM Yes 1 –
Elp3 mcm5U U cm5U AcOH addition tRNA 34 SAM, acethyl-CoA Yes 1 ELP3
RlmN m2A A m2A Methylation tRNA
rRNA
37
2503
SAM Yes 1 –
Cfr m8A A m8A Methylation rRNA 2503 SAM Yes 1 –
TtcA s2C C s2C Thiolation tRNA 32 Cysb, ATP No 1 –
TYW1 yW m1G imG-14 Imidazoline ring formation tRNA 37 SAM, pyruvate Yes 2 TYW1/RSFAD
RlmD/RumA m5U U m5U Methylation rRNA 1939 SAM No 1 –
RlmC/RumB m5U U m5U Methylation rRNA 747 SAM No 1 –
a The substrates are deduced from MiaB-catalyzed reaction. Although in vitro reconstitution of ms2t6A formation has not been succeeded, the requirements fo these co-factors are es-
timated by the reaction mechanism of homologous enzyme, MiaB and RimO.
b A sulfur atom originates from persulﬁde of Cys mediated by cysteine desulferase IscS.
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for Thermotoga maritima MiaB with [4Fe-4S] clusters in the presence
of SAM under anaerobic conditions [32]. MiaB uses two molecules of
SAM for methylthiolation. During this reaction, one SAM is converted
to SAH, whereas the other is converted to a 5′-dAdo radical. Although
radical SAM-dependentmethyltransferases contain a single Fe/S cluster,
MiaB harbors two Fe/S clusters [23]; the ﬁrst cluster is chelated by the
radical SAM domain, and the second is bound by the N-terminal
UFP0004 domain. Similar to the case of RlmN or Cfr, the ﬁrst cluster in
the radical SAM domain is responsible for the generation of a 5′-dAdo
radical. The source of the sulfur atom of ms2i6A has not yet been deter-
mined. Structural studies of T. maritima MiaB and RimO identiﬁed a
“pentasulﬁde bridge” consisting of exogenous sulfurs spanning be-
tween the two [4Fe-4S] clusters [35]. Addition of sulﬁde under strongly
reducing conditions facilitates multiple turnover by MiaB without
sacriﬁcing Fe/S clusters as the source of sulfur, suggesting that exoge-
nous sulﬁde is utilized as the sulfur donor for the methylthio group of
ms2i6A [35]. Moreover, when MiaB is incubated with SAM without a
reducing agent,methanethiol is released from the denaturedMiaB, indi-
cating thatmethyl group of SAM is transferred to an acid-labile sulfur on
MiaB [36]. In fact, methylthiol can serve as a substrate of MiaB and be
directly incorporated in ms2i6A [35]. Based on these observations, a cat-
alytic mechanism of methylthiolation of ms2i6A has been proposed
(Fig. 3C). First, exogenous sulﬁdes are incorporated into the oligo-
meric sulfur bridge between two Fe/S clusters of MiaB, followed by
methyltransfer from SAM to the terminal sulfur of the sulfur oligo-
mer. The 5′dAdo radical produced by the ﬁrst cluster abstracts the H-
atom at the C2 position of i6A37 of the tRNA. Finally, the methylthiol
of the oligomeric sulfur bridge is transferred to the activated C2 position
to complete the reaction. In this catalyticmechanism, the second cluster
plays a role in binding and activating the methylthio moiety [36]. In
addition, the second cluster appears to be involved in turnover of the
reaction [36]. Although source of such exogenous sulﬁdes has not
been determined, hydrogen sulﬁde generated from endogenous
persulﬁdes and polysulﬁdes [37,38] might be the source of sulfur
for ms2i6A.
4. Tricyclic base formation of wybutosine mediated by TYW1
Wybutosine (yW) and its derivatives (Fig. 4A) are ﬂuorescent nucle-
osides found at position 37 of tRNAs from eukaryotes and archaea
[39–42]. The base of yW is a tricyclic purine with a bulky side chain.
yW and hydroxywybutosine (OHyW) are present in tRNAPhe from
yeast and mammals, respectively. Wyosine (imG), isowyosine (imG2),
and methylwyosine (mimG) are present in archaeal tRNAs. yW confers
conformational rigidity on the anticodon loop of tRNA. On the ribosome,
yW stabilizes the codon–anticodon interaction by stacking on the base
pair formed by the ﬁrst letter of the codon and the third letter of theanticodon, thereby maintaining the reading frame by preventing a
frameshift [43,44]. Hypomodiﬁcation of OHyW occurs in cells infected
by human immune deﬁciency virus (HIV-1) [45]. Because pro-
grammed-1 ribosomal frameshifting at the gag-pol junction of HIV-
1 RNA is a highly conserved recoding event required for active viral
expression [46], yW frequency in tRNA might be involved in the reg-
ulation of viral infection.
The biogenesis of yW and its derivatives has been extensively stud-
ied. All the genes responsible for yW formation have been identiﬁed in
yeast [47–49]. Five enzymes, TRM5 and TYW1–4, participate in the
multi-step consecutive reactions involved in yW synthesis (Fig. 4B).
yW biogenesis is initiated by 1-methylation of G37 to form m1G37, a
reaction catalyzed by TRM5 [50]. TYW1 is the sole Fe/S protein involved
in the biosynthetic pathway of yW [47]. Because 4-demethylwyosine
(imG-14) accumulates in a TYW2 knockout strain [47,49], TYW1 has
been proposed to be involved in the ring formation to synthesize imG-
14 fromm1G. Although the enzymatic activities of yeast andmammali-
an TYW1have not yet been directly demonstrated, formation of imG-14
from m1G, catalyzed by the archaeal homolog of TYW1, has been suc-
cessfully reconstituted in vitro [51]. Archaeal TYW1 catalyzes ring for-
mation of the tricyclic purine base on tRNA by condensation of m1G
with two carbons of pyruvate to form imG-14. Next, TYW2 transfers
the α-amino-α-carboxypropyl group from SAM to the tricyclic core of
imG-14 to form yW-72 [47,52]. TYW3 methylates the N4 position of
yW-72 to form yW-58 [47]. Finally, TYW4 catalyzes both methylation
and methoxycarbonylation of yW-58 using two SAMs and one bicar-
bonate to synthesize yW [47,53]. In mammals and several species of
fungi, including Aspergillus oryzae, the β-carbon of the side chain in
yW is further hydroxylated to form OHyW [54]. An additional enzyme,
TYW5, which harbors a Jumonji C domain, catalyzes hydroxylation of
yW-72 to formOHyW-72 [54,55]. Subsequently, OHyW-72 is converted
to OHyW in a reaction mediated by TYW4 [54].
NFS1 is a cysteine desulfurase required for Fe/S biogenesis [56]. Inhi-
bition of NFS1 expression results in severe reduction of yW [47], indicat-
ing that Fe/S clusters play a critical role in yW synthesis. TYW1 contains
a canonical radical SAM motif with three conserved Cys residues that
potentially coordinate a Fe/S cluster [47]. The functional importance of
these Cys residues for yW formation was conﬁrmed by in vivo comple-
mentation studies in yeast [47,57]. Structural analysis revealed that
archaeal TYW1 harbors two [4Fe-4S] clusters [57,58]. Young and
Bandarian [51,59] succeeded in reconstituting formation of imG-14
from m1G, catalyzed by Methanococcus jannaschii TYW1, in vitro.
Those authors screened several metabolites as the two-carbon
source for imG-14 formation, and ultimately identiﬁed pyruvate as the
substrate for the TYW1-catalyzed reaction. Stable-isotope labeling
experiments using [13C] pyruvate revealed that the C2 and C3 carbons
of pyruvate are incorporated to imG-14. Based on biochemical and spec-
troscopic approaches, a catalyticmechanism involving two Fe/S clusters
Fig. 2.Methylation by RlmN and Cfr. The secondary structures of a part of domain V of E. coli 23S rRNA (A) and tRNAGlu(B) with post-transcriptional modiﬁcations; N2-methylguanosine
(m2G), pseudouridine (Ψ), 2′-O-methylcytidine (Cm), 5-hydroxycytidine (ho5C), 2-methyladenosine (m2A), 2′-O-methyluridine (Um), 5-methylaminomethyl-2-thiouridine (mnm5s2U),
and 5-methyluridine (m5U). C, Biosynthesis scheme ofm2A andm2,8A. The reactionsmediated by RlmN and Cfr are independent. D, Proposed catalytic mechanism to formm2A catalyzed
by RlmN (see text). H-atoms of methyl group from SAM and H-atom of C2 of adenine base are colored in red and blue, respectively.
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cluster is chelated by three Cys residues in the radical SAM domain,
which catalyzes reductive cleavage of SAM to generate 5′-dAdo radical
(·Ado). Based on the EPR and Mössbauer data, the second Fe/S cluster is
thought to coordinate pyruvate directly [60]. Alternatively, it is speculatedthat the pyruvate is ﬁxed through a Schiff base with a conserved essen-
tial Lys residue [51,59]. The 5′-dAdo radical produced by the ﬁrst cluster
might directly (or indirectly, through some residues of TYW1) abstract
the hydrogen from the methyl group of m1G. This methyl radical then
adds to C2 of pyruvate, followed by homolytic scission of the C1–C2
Fig. 3.Methylthiolaion by MiaB and MtaB. A, Secondary structures of E. coli tRNATrp (left panel) and human tRNALys (right panel) with post-transcriptional modiﬁcations; 4-thiouridine
(s4U), dihydrouridine (D), 2′-O-methylcytidine (Cm), 7-methylguanosine (m7G), 2-methylthio-N6-isopentenyladenosine (ms2i6A), 5-methoxycarbonylmethyl-2-thiouridine
(mcm5s2U), 2-methylthio-N6-threonylcarbamoyladenosine (ms2t6A), 5-methylcytidine (m5C), 5,2′-O-dimethyluridine (m5Um), and 1-methyladenosine (m1A). B, Biosynthesis scheme
of ms2i6A and ms2t6A. Modifying enzymes are colored in green. C, Proposed catalytic mechanism to form ms2i6A from i6A catalyzed by MiaB (see text).
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group of guanine attacks C3 carbon of pyruvate via nucleophilic addi-
tion to form the ring of imG-14, with release of a water molecule.Further investigations will be required to elucidate the detailed mecha-
nism of the catalytic reaction. In addition, the enzymatic activity of
eukaryotic TYW1 has not yet been directly demonstrated. Eukaryotic
Fig. 4. Tricyclic base formation of wybutosine. A, Secondary structure of S. cerevisiae tRNAPhe (left panel) with post-transcriptional modiﬁcations; N2-methylguanosine (m2G),
dihydrouridine (D), N2,N2-dimethylguanosine (m22G), 2′-O-methylcytidine (Cm), 2′-O-methylguanosine (Gm), wybutosine (yW), pseudouridine (Ψ),5-methylcytidine (m5C),
7-methyladenosine (m7A), 5-methyluridine (m5U), and 1-methyladenosine (m1A). Chemical structures (right panels) of wybutosine (yW) and hydroxywybutosine (OHyW). B, Biosyn-
thesis scheme of yW. Functional groups added at each step are colored in blue. Modifying enzymes are colored in green. C, Proposed catalytic mechanism to form imG-14 from m1G
catalyzed by TYW1 (see text). C2 and C3 of pyruvate are shown in red.
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terminal radical SAM domain [47]. An additional factor, such as FMN,
might be required for the reaction catalyzed by eukaryotic TYW1.
5. The Elongator complex is essential for tRNAwobblemodiﬁcations
Several eukaryotic tRNAs responsible for NNA codons bear
5-methoxycarbonylmethyluridine (mcm5U) and its derivatives,
including 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U),
5-methoxycarbonylmethyl-2′-O-methyluridine (mcm5Um), 5-
carbamoylmethyluridine (ncm5U), 5-carbamoylmethyl-2'-O-
methyluridine (ncm5Um), and 5-methoxycarbonylhydro-
xymethyluridine (mchm5U) at the wobble position (Fig. 5A)[61–63].
The Elongator complex (Elp) associated with actively transcribing
RNA polymerase II [64] is responsible for this wobble modiﬁcation
[65]. Elongator is composed of six components, ELP1–6 [66,67]; ELP3
is a Fe/S protein that has been reported to be a histone acetyltransferase
[68]. Deletion of each component of the complex elicits pleiotropic
phenotypes, including slow growth, temperature sensitivity [66,69,
70], reduced histone acetylation [67], defects in exocytosis [71], elevat-
ed sensitivity to DNA damage [72], defects in telomeric gene silencing
[72], deﬁcient demethylation of the paternal genome [73], impairment
of migration and differentiation by cortical neurons [74], and reduced
resistance to the Kluyveromyces lactis killer toxin [69]. Intriguingly, the
defects in transcriptional elongation, exocytosis, telomeric gene silenc-
ing, and DNA damage response observed in the Elongator mutants are
suppressed by overexpression of tRNAs that contain mcm5s2U at the
wobble position in the wild-type background [75,76]. Moreover,
deletion of tuc2 (ncs2), which is responsible for 2-thiouridine formation
of mcm5s2U, results in phenotypes similar to those observed in the
Elongator mutants [75,76]. These observations suggest that the
telomeric gene silencing and DNA-damage response mediated by the
Elongator complex can be explained by the function of tRNA wobble
modiﬁcations, which might be required for accurate and efﬁcient
expression of gene products involved in those processes.
The lack of 5-methoxycarbonylmethyl modiﬁcation of mcm5s2U in
tRNAs could inﬂuence the decoding ability of their respective cognate
codons. In Elongator mutants of S. cerevisiae, in vivo ribosome distribu-
tion analysis revealed a clear accumulation of ribosomes at AAA, GAA,
and CAA codons, indicating that these codons were translated less efﬁ-
ciently by hypomodiﬁed tRNAs [77]. Telomeric gene silencing of
S. cerevisiae is mediated by Sir4 function. Elongator mutants express
lower levels of Sir4, which contains abundant AAA codons, due to the
accumulation of hypomodiﬁed tRNALys lacking the mcm5 modiﬁcation
[75,76]. Lys is speciﬁed by both AAA and AAG codons; however, AAG co-
dons are redundantly deciphered by a tRNALyswith themcm5s2UUU an-
ticodon and another with the CUU anticodon. By contrast, AAA codons
are deciphered only by tRNALys with the mcm5s2UUU anticodon. Thus,
lack of the mcm5 modiﬁcation could cause a severe reduction in AAA
decoding. In ﬁssion yeast, Cdr2, a protein kinase required for cell cycle
progression, is translated less efﬁciently in the elp3mutant, due to the
abundant usage of Lys codons in the Cdr2 gene [78]. Intriguingly, synon-
ymous alteration of Lys codons from AAA to AAG rescues expression of
the Cdr2 protein. A similar mechanism may be involved in the expres-
sion of Atf1 and Pcr, which are transcription factors induced by oxida-
tive stress [79]. These ﬁndings provide an attractive mechanism by
which tRNA wobble modiﬁcations mediated by the Elongator complex
might regulate translational efﬁciency of target mRNAs as a function
of their codon usage, thereby making a fundamental contribution to
cellular functions.
Among the components of the Elongator complex, only Elp3 harbors
enzymatic domains, including a radical SAMdomain and histone acetyl-
transferase (HAT) domain. Genetic mutations of these domains fail to
rescue the phenotypes observed in the Elp3 deletion strain [76],
suggesting that both enzymatic activities are necessary for Elp3 func-
tion. In all Elongator components, only Elp3 is widely distributed inarchaeal species. Recently, Selvadurai and colleagues [80] succeeded in
reconstituting formation of 5-carboxymethyluridine (cm5U) (Fig. 5B)
in tRNA byMethanocaldococcus infernus Elp3 protein (MinElp3) in the
presence of Na2S2O4, SAM, and acetyl-CoA under reducing conditions.
In this reaction, Elp3 transfers the carboxymethyl group of acetyl-CoA
to the C5 position of a uracil base (U34) at the wobble position of the
tRNA. This experiment clearly demonstrated that Elp3 is the sole com-
ponent of the Elongator complex that generates a tRNAwobble modiﬁ-
cation. Elp3 contains the CxxxxCxxC motif in its radical SAM domain,
and [4Fe-4S] cluster formation is necessary for catalysis in vitro. The
reconstituted reaction was accompanied by the release of 5′-dAdo and
CoA as by-products, indicating that Elp3 generates the 5′-dAdo radical
and hydrolyzes the thioester of acetyl-CoA. On the basis of biochemical
analyses, a mechanism for the Elp3-catalyzed reaction has been pro-
posed (Fig. 5B). In this model, after the association of Elp3 with tRNA,
the radical SAMdomain catalyzes the reductive cleavage of SAM to gen-
erate the 5′-dAdo radical. The 5′-dAdo radical then abstracts theH-atom
of the methyl group of acetyl-CoA bound to the HAT domain, thereby
generating acetyl radical, which in turn adds to the C5 carbon of U34
to form a C\C bond. Loss of an electron and the abstraction of the pro-
ton at C5 results in the formation of tRNA-acetyl-CoA conjugate, and hy-
drolysis of this conjugate produces cm5U 34 on tRNA. In S. cerevisiae,
cm5U is not a ﬁnalmodiﬁcation in tRNA [81], andmight represent an in-
termediate in the synthesis of mcm5U and ncm5U. cm5U is further
methylated to form mcm5U by the SAM-dependent methyltransferase
Trm9p [82]. To form ncm5U, ammoniummight attack the carbonyl car-
bon of the thioester of the tRNA-acetyl-CoA conjugate; however, this
has not yet been experimentally veriﬁed. The proposed reaction scheme
suggests that both radical SAM and HAT domains work coordinately to
synthesize the wobble modiﬁcation. Structural studies will reveal how
Elp3 recognizes tRNA, and how the two domains catalyze the composed
chemical reaction.
In eukaryotes, other components of Elongator complex are essential
for tRNA modiﬁcations [65]. The Elp4-5-6 subcomplex, which adopts a
hexameric RecA-like ATPase structure, is involved in tRNA binding [83],
indicating that eukaryotic wobble uridine formation occurs via a mecha-
nism more complex than that of the archaeal system, even though the
main catalytic function of Elp3 is likely to be conserved. In addition,
many regulatory factors are present in eukaryotic Elongator complex
[65,84]. Further analyses are necessary for a deeper understanding of
the function and regulation of Elongator complex in eukaryotes.
6. Deazapurine formation by QueE
Queuosine (Q) is a guanosine derivative with a 7-deazapurine core
structure found at thewobble position of tRNAs responsible for NAY co-
dons: tRNAs for Tyr, His, Asp and Asn (Fig. 6A) [85,86]. Q plays a role in
maintaining translational accuracy [45]. As Q is also required for the vir-
ulence of Shigella ﬂexneri [87,88], biogenesis of Q is a pharmaceutical
target for antibacterial inhibitors [89]. Although Q and its derivatives
are present in tRNAs ofmost eukaryotes and bacteria [86], Q is only syn-
thesized in bacteria, and eukaryotes lack the Q biosynthetic pathway
[90]. Eukaryotes acquire queuine, which is a free base of Q, as a dietary
nutrient and/or from microﬂora. In bacteria, preQ1, a precursor of Q, is
synthesized from GTP thoughmulti-step reactions mediated by a series
of enzymes, including GCHI, QueD, QueE, QueC, and QueF (Fig. 6B) [2].
Thus synthesized preQ1 is incorporated to tRNA by replacing the gua-
nine base at position 34 via transglycosylation catalyzed by tRNA-
guanine transglycosylase (TGT) [91]. In eukaryotes, eukaryotic TGT
(eTGT) incorporates the free Q-base taken from diet or microﬂora to
tRNA via transglycosylation reaction.
In bacterial Q biogenesis, QueE is a sole radical SAM enzyme which
catalyzes a ring contraction reaction to generate the 7-deazapurine
core structure of Q [2,92]. QueE catalyzes conversion of 6-carnoxy-
5,6,7,8-tetrahydropterin (CPH4) to 7-carboxy-7-deazaguanine (CDG)
in the presence of SAM and Mg2+. Based on structural studies of
Fig. 5. Carboxymethylation by ELP3. A, 5-Methoxycarbonylmethyluridine (mcm5U) and its derivatives are found at the wobble position (position 34) of eukaryotic tRNAs (left panel).
Chemical structures of mcm5U, mcm5s2U, mcm5Um, mchm5U, ncm5U and ncm5Um are shown in the right panels. B. Proposed catalytic mechanism to form 5-carboxymethyluridine
(cm5U) catalyzed by archaeral Elp3.
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strates of pre- and post-reaction states [93], a detailed mechanism has
been proposed for ring compaction catalyzed by QueE (Fig. 6C). 5′-
dAdo radical, produced by reductive cleavage of SAM, may abstract
the H-atom of C6 of CPD4; Mg2+ coordinates with CPD4 and may facili-
tate this reaction. Generation of the ﬁve-membered pyrrole ring could
occur via several distinct routes. Next, the amino-centered radical
abstracts the H-atom of dAdo to regenerate the 5′-dAdo radical, which
can be used for the next round reaction. Finally, CDG is formed by the
elimination of the amino group.
7. 2-Thiocytidine formation of tRNA by TtcA
In tRNAs from E. coli and other bacteria, there are four species of
sulfur-containing modiﬁcations; 4-thiouridine (s4U) at position 8, 2-
thiouridine (s2C) at position 32, 5-methylaminomethyl-2-thiouridine
(mnm5s2U) at position 34, and ms2i6A at position 37 [19]. In addition
to ms2i6A, described above, s2C32 is also synthesized via a Fe/S-
dependent pathway, whereas s4U8 andmnm5s2U34 are synthesized in-
dependently of Fe/S formation [94]. TtcA (two-thio-cytidine), which is
responsible for s2C32 formation [95], contains a PP-loop motif in its N-
terminal region and two CXXC motifs. Recently, TtcA was found to con-
tain [4Fe-4S] cluster chelated by three essential Cys residues [96]. More-
over, formation of s2C32 on tRNA by TtcA and IscS has been successfully
reconstituted in the presence of ATP and L-Cys [96]. Because the PP-loop
is a motif of the N-type ATP pyrophosphatase involved in the forma-
tion of adenylate intermediate of the substrate [97], TtcA probably
adenylates the C2 carbonyl oxygen using ATP. Subsequently, thepersulﬁde sulfur from Cys is transferred to the C2 carbon, concomitant
with the release of AMP. However, no Cys residue in TtcA that forms
persulﬁde with a sulfur donor has been identiﬁed. While, unliganded
iron in Fe/S cluster is supposed to serve as the acceptor of the sulfur
atom, in the similar manner in which the second cluster of RimO
binds to the free sulfur atom.
8. Fe/S cluster involved in RNA recognition and stabilization of
protein folding
As described above, Fe/S cluster plays a critical role in various enzy-
matic reactions involving electron transfer. However, in some cases, Fe/
S clusters are involved in other processes, including substrate recogni-
tion and stabilization of protein folding.
Threemethyltransferases responsible for 5-methyluridine (m5U) are
present in E. coli; TrmA/RumT [98] for m5U54 in tRNAs, RlmC/RumB for
m5U747 in 23S rRNA, and RlmD/RumA for m5U1939 in 23S rRNA [99,
100]. Although all of these enzymes share the similar amino acid
sequence, only RlmC/RumB and RlmD/RumA harbor Fe/S cluster bind-
ing motif [101]. Structural analysis of RlmD/RumA complexed with
rRNA fragment and SAMrevealed that the Fe/S cluster is not responsible
for the catalytic reaction, but involved in the substrate rRNA binding
[102,103]. One sulfur atom of the Fe/S cluster is exposed to the solvent,
and interactswith the uracil base of U1940mediated by twowatermol-
ecules. This observation veriﬁed that the Fe/S cluster of RlmD/RumA is
involved in the RNA binding. Tryptophanyl-tRNA synthetase (TrpRS)
containing Fe/S cluster is another example for the Fe/S cluster to be in-
volved in RNA recognition [104,105]. In Bacillus subtillis, RlmC/RumB
Fig. 6.Ring compaction to form7-deazapurine. A, Queuosine (Q) is present at thewobble position (position 34) of tRNAswith QUNanticodons (left panel) and its chemical structure (right
panel). B, Biosynthesis scheme of Q. Intermediates are 7,8-dihydroneopterin triphosphate (H2NTP), 6-carboxy-5,6,7,8-tetrahydropterin (CPH4), 7-carboxydeazaguanine (CDG), 7-cyano-
7-deazaguanine (preQ0), 7-aminomethyl-7-deazaguanine (preQ1), and epoxyqueuosine (oQ).Modifying enzymes are colored in green. C, Proposed catalyticmechanism to formCDG from
CPH4 catalyzed by QueE. H-atom at C6 of CPH4 is colored in red.
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RlmCD, which catalyzes the formation of both m5U747 and m5U1939
in 23S rRNA [106]. As RlmCD harbors the Fe/S cluster binding motif,
RlmCD is likely to use the Fe/S cluster for rRNA recognition. The single
mutation of one of Cys residues which chelate the Fe/S cluster resulted
in decreased solubility of RlmD/RumA [102]. In addition, decomposition
of the Fe/S cluster by oxidation precipitated RlmD/RumA [101]. These
ﬁndings clearly indicate that the Fe/S cluster of these methyltransfer-
ases is required for protein stability or folding.
9. Alteration of RNA modiﬁcation under environmental conditions
Fe/S clusters easily react with reactive oxygen species (ROS),
resulting in the loss of ferric ions, which fuel the Fenton reaction to pro-
duce more ROS [107]. Hence, RNA modiﬁcations mediated by Fe/Scluster enzymes are sensitive to oxidative stresses. In addition, the cel-
lular concentration of Fe2+ is another factor that modulates the activity
of Fe/S cluster enzymes. In fact, 2-methylthio modiﬁcation of ms2i6A in
tRNAs from E. coli, Staphylococcus typhimurium, and Pseudomonas
aeruginosa is decreased upon iron depletion [108]. Because animals
harbor various iron-chelating proteins, including transferrin and
lactoferrin, the levels of ms2i6A or other Fe/S-dependent modiﬁcations
can be altered when pathogenic bacteria infect host cells. Indeed, lack
of 2-methylthio modiﬁcation of ms2i6A has been observed in E. coli
injected into host animals [109], suggesting that pathogenic bacteria
can regulate the levels of RNAmodiﬁcations by sensing the iron concen-
tration in host cells. Considering that translational efﬁciency and accu-
racy can be controlled by tRNA modiﬁcations, altered frequency of
tRNA modiﬁcation would affect decoding properties of tRNA, leading
to a global alteration of the proteome. Consistent with this idea, loss
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involved in aminoacid biogenesis [22], suggesting that iron depletion
can impinge on aminoacid metabolism.
10. Human diseases associated with Fe/S-dependent
RNAmodiﬁcations
Lack of RNA modiﬁcation can cause functional defects of RNA,
leading to the molecular pathogenesis of various diseases. Our
group previously reported that the lack of tRNAmodiﬁcation is a pri-
mary cause of mitochondrial encephalomyopathic diseases [110,
111]. These ﬁndings provided the ﬁrst conﬁrmation of a human dis-
ease caused by an RNAmodiﬁcation disorder. In addition, large-scale
disease-associated exome analyses have identiﬁed numerous genes
encoding tRNA/rRNA-modifying enzymes [112].
More than 200 million people worldwide suffer from Type 2 diabe-
tes (T2D), which is characterized by deﬁcient insulin secretion from
pancreatic β-cells and insulin resistance. Whole-genome association
studies reveal that mutations in the CDK5 regulatory subunit associated
protein 1-like 1 (CDKAL1) (Table 1) are one of the most reproducible
risk factors for T2D [113,114]. CDKAL1 is the human homolog of bacte-
rial MtaB, which is responsible for 2-methylthio modiﬁcation of ms2t6A
at position 37 of tRNALys [26]. Knockout of CDKAL1 results in complete
loss of 2-methylthio modiﬁcation of ms2t6A [115]. Furthremore,
β-cell-speciﬁc CDKAL1 knockout mice exhibit pancreatic islet hypertro-
phy and impaired blood glucose control. These mice are also hypersen-
sitive to the high-fat diet–induced endoplasmic reticulum (ER) stress
response. These observations suggest that mistranslation induced by
hypomodiﬁed tRNALys could produce aberrant proteins, including pro-
insulin, in β-cells.
Mutations in components of the Elongator complex are associated
with some neurological disorders. Allelic variants of ELP3 detected in
three human populations have been associatedwith amyotrophic later-
al sclerosis (ALS) [116]. In ﬂies, a mutagenesis screen for genes required
for neuronal function and survival identiﬁed two different loss-of-
function mutations in ELP3. In addition, knockdown of Elp3 in zebraﬁsh
resulted in motor axonal abnormalities [116]. Other components of the
Elongator complex are also associated with neurological disorders.
Pathogenic mutations in human ELP1 (IKAP/IKBAP) are associated
with familial dysautonomia (FD) [117–119], and ELP1 has also been
associated with bronchial asthma in children [120]. On the other hand,
ELP4 gene has been associated with Rolandic epilepsy [121].
11. Conclusion and perspective
Recent studies providemechanistic insights into biogenesis of sever-
al RNAmodiﬁcationsmediated by radical SAM enzymes. 5′dAdo radical
generated by Fe/S cluster initiates complex chemistries includingmeth-
ylation, methylthiolation, carboxymethylation, tricyclic purine forma-
tion, and deazaguanine formation. Some radical SAM enzymes have
second Fe/S cluster required for binding of substrate and intermediate.
In methylation and methylthiolation, radical SAM enzymes employ
two molecules of SAM to catalyze two different reactions; methylation
and 5′ dAdo radical formation. Radical SAM enzymes would have
evolved to catalyze various types of reactions to expand chemical diver-
sities of RNA modiﬁcations. Since Fe/S cluster is sensitive to ROS, and
RNAmodiﬁcations can be regulated by iron concentration, it is plausible
to speculate that radical SAM enzymes play a regulatory role in protein
synthesis by sensing cellular metabolic status.
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